Clinical trial condition

AML

Explore clinical trials studying AML. Study availability and eligibility vary by location and protocol.

139 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

AML trial results

Not yet recruiting

Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML

NCT06758726

Conditions: AML
Locations: Not specified

View Trial Details

Not yet recruiting

Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia

NCT06643195

Conditions: AML
Locations: Hebei Medical University Second Hospital Shijiazhuang, Hebeisheng, China

Zhengzhou University First Affiliated Hospital Zhengzhou, Henan, China

The 960th Hospital of the Joint Service Support Force of the Chinese People's Liberation Army Jinan, Shandong, China

People's Liberation Army The General Hospital of Western Theater Command Chengdu, Sichuan, China

View Trial Details

Enrolling by invitation

Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL)

NCT06499025

Conditions: AML, Neoantigen, t(8;21)
Locations: Shenzhen University General Hospital Shenzhen, Guangdong, China

View Trial Details

Enrolling by invitation

Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia

NCT03031249

Conditions: AML
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

NCT05153226

Conditions: AML, CMML, Graft vs Host Disease, +4 more
Locations: Uniklinik RWTH Aachen Aachen, Germany

Univeristätsklinikum Augsburg Augsburg, Germany

Klinikum Chemnitz gGmbH Chemnitz, Germany

Universitätsklinikum Köln Cologne, Germany

View all 23 locations

View Trial Details

Active, not recruiting

A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

NCT05796570

Conditions: AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

NCT03739502

Conditions: ALL, AML, Bone Marrow Diseases, +16 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Active, not recruiting

ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial

NCT06664879

Conditions: AML
Locations: The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML

NCT06744556

Conditions: AML
Locations: Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, not recruiting

Venetoclax in Patients With MDS or AML in Relapse After AHSCT

NCT05226455

Conditions: AML, MDS
Locations: CHU d'Angers Angers, France

CHU de Grenoble Grenoble, France

Hôpital Dupuytren Limoges, France

Hôpital Saint-Eloi Montpellier, France

View Trial Details

AML

AML trial results

Related conditions